Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674248 | SCV000799552 | likely pathogenic | Neuronal ceroid lipofuscinosis 8 | 2018-04-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001381243 | SCV001579562 | pathogenic | Neuronal ceroid lipofuscinosis | 2020-06-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu133*) in the CLN8 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CLN8-related conditions. ClinVar contains an entry for this variant (Variation ID: 558034). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Loss-of-function variants in CLN8 are known to be pathogenic (PMID: 15024724). For these reasons, this variant has been classified as Pathogenic. |